Celsius Therapeutics
Cambridge
About Celsius Therapeutics
Celsius Therapeutics is a biotechnology company that develops precision medicines for cancer and autoimmune disease patients. The company is a group of scientists, technologists, computational biologists, clinicians, and drug hunters who use single-cell genomics and machine learning analysis to find new drugs. Celsius Therapeutics was founded in 2018 and is headquartered in Cambridge, Massachusetts.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $148.0M
- Funding stage: M&A
- Last round: Series B (Mar 2022)
- Website: celsiustx.com
- Phone: 857-776-7400
Industries & Categories
Biotechnology, Emergency Medicine, Genetics, Health Care, Precision Medicine
Social Profiles
Canonical: https://fsome.com/organization/celsius-therapeutics-90467 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.